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Bulleted statements 
 
What’s already known about this topic? 
 Leptin is an adipocyte-secreted hormone that regulates weight.  
 Leptin is known to link lipid metabolism with inflammation in various cell types.  
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 Sebaceous glands are capable of responding to different stimuli by an altered secretion of lipids and 
production of inflammatory mediators. 
 
What does this study add? 
Leptin was recognized as a possible pro-inflammatory player in sebaceous gland biology since sebocytes 
responded to leptin stimulation with pro-inflammatory changes in the sebaceous lipid profile and with an 
increased expression of inflammatory enzymes and cytokines. 
 
Summary 
Background: Leptin, the adipocyte-secreted hormone that regulates weight, is known to link lipid 
metabolism with inflammation in various cell types, however its role in human sebocytes has not yet been 
investigated.  
 
Objectives: The purpose of the study was to investigate the effects of leptin in human sebaceous gland 
biology. 
 
Methods: Ob-Rb expression was detected by real time quantitative RT-PCR and by immunochemistry. 
Lipid analysis was performed by high performance thin layer chromatography, gas-chromatography-mass 
spectrometry and time of flight mass spectrometer mass detection. Lipid bodies were visualized by 
BODIPY staining using fluorescent microscopy and measured by flow cytometry. IL-6 and IL-8 mRNA 
levels were assessed by real time quantitative RT-PCR and their release was evaluated by enzyme-linked 
immunosorbent assay. COX-2 and 5-LOX protein expressions as well as the phosphorylation of p65 and 
STAT3 were determined by Western blot analysis.  
 
Results: Expression of Ob-Rb was detected in human sebaceous glands and in cultured human SZ95 
sebocytes. The treatment of SZ95 sebocytes with leptin led to an enlargement of intracellular lipid bodies, 
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increased the ratios of unsaturated/saturated fatty acids and decreased vitamin E levels. Further supporting 
a pro-inflammatory role, leptin induced COX-2 and 5-LOX expression in SZ95 sebocytes and augmented 
the production of IL-6 and IL-8 cytokines. Upon leptin treatment, STAT-3 and NF-κB pathways were 
activated indicating that these known leptin signalling pathways are active in human sebocytes. 
 
Conclusions: Our findings suggest that leptin signalling may be involved in the pro-inflammatory 
regulation of sebaceous lipid metabolism and in the induction of inflammatory enzymes and cytokines. 
 
Introduction 
Leptin is an adipocyte-derived hormone/cytokine that links nutritional status with neuroendocrine and 
immune functions
1
. Acting on its receptors in the hypothalamus leptin is a key player in regulating energy 
intake and expenditure
2,3
. Besides reflecting the amount of energy stored in the adipose tissue, leptin 
modulates the function of a wide variety of cell types
4
. The full-length form of the leptin receptor (Ob-
Rb) is known to be predominantly responsible for active signal transduction leading to modification of 
intracellular lipid metabolism, activation of several downstream pathways, such as the STAT-3 and the 
IRS1/PI3K/Akt/NF-κB ones, and an increased production of pro-inflammatory chemokines5-7. In addition, 
leptin increases the expression levels of enzymes involved in the production of inflammatory mediators
8,9 
thus providing an important cross-talk between lipid metabolism and inflammation at the cellular level.   
Sebaceous glands and hair follicles form together the pilosebaceous units, whose primary function is 
the production of sebum
10
. While an altered lipid composition associated with an increased excretion of 
sebum is one of the most important factors in the development of acne, on the other hand, its impaired 
production has been proposed as a key feature in atopic dermatitis
11
. Sebaceous glands also play a central 
role in skin inflammation
10,12
. Pattern recognition receptors such as TLR2, TLR4, and TLR6 are 
expressed in sebocytes
13,14
, and their activation increases the secretion of both pro- and anti-inflammatory 
cytokines (IL-6 and IL-10 respectively), chemokines (IL-8), antimicrobial lipids, peptides, periglandular 
peptides and neuropeptides
15-17
.  
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It is conceivable, therefore, that known signalling mechanisms that mediate leptin actions may also be 
active in sebocytes. Indeed, sebocytes provide an interesting cell model to study abundant, primary 
lipogenesis and mediation of inflammatory responses
18
. 
In this study, we provide evidence that the functionally active full-length form of the leptin receptor 
(Ob-Rb) is expressed in human sebaceous glands and in cultured human SZ95 sebocytes and present a 
systematic analysis on the effect of leptin on SZ95 sebocytes regarding lipogenesis and inflammation. 
 
Materials and methods 
Immunohistochemistry, immunocytochemistry  
Anonymised formalin-fixed and paraffin embedded sections of human skin from the tissue archive of the 
Department of Dermatology, University of Debrecen were acquired after the approval of the Regional and 
Institutional Ethics Committee, University of Debrecen. SZ95 sebocytes were cultured in chamber slides 
(LabTek, Thermo Scientific, Rochester, NY), in a density of 10,000 cells/well. Immunohistochemistry 
and immunocytochemistry was carried out by using a purified primary antibody to the functionally active 
full length form of the leptin receptor (Ob-Rb; 250739, Abbiotec, San Diego, CA). Staining protocols are 
presented in supplementary information online. 
 
Cell culture and cell treatment 
The immortalized human sebaceous gland cell line SZ95 was cultured as described previously
19
. Human 
recombinant leptin (R&D Systems, Minneapolis, MN) was dissolved and stored at −70°C according to 
the manufacturer’s protocol. For an optimal stimulation, leptin was used at the concentration of 20 nM, 
which is within the normal range of human serum levels
6
. Leptin was monitored for endotoxin 
contamination using the Limulus Endosafe
®
 KTA2™ assay (Charles River Endosafe, Charleston, SC). 
The endotoxin level was <0.02 EU per 1 μg. Parallel experiments were performed using equivalent levels 
of lipopolysaccharides (LPS; 3 pg/ml) that did not result in lipid body enlargement or in STAT3 and p65 
phosphorylation (Supplement 1) and did not induce the expression levels of COX-2 or  5-LOX proteins.  
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Lipid analyses 
SZ95 sebocytes were cultured in epidermal growth factor-free medium, harvested at the indicated time 
points, then counted and stored at -80°C until processing. Lipid extraction was performed as previously 
reported with slight modifications to adapt it to a multiple lipid analyses protocol
20
 (Supplementary 
information online).  
 
Lipid body detection and enumeration 
Sebocytes were cultured on LabTek chamber slides (Thermo Scientific) and were treated with human 
recombinant leptin, for 12 and 24 h. Lipid bodies with size over 3 m in SZ95 sebocyte colonies were 
enumerated with a ×100 objective lens for 100 consecutive cells in each slide (Supplement 2). Staining 
protocols and information on microscopes and acquisition software are detailed in Supplementary 
information online.  
 
Western blotting 
Cells were collected at the indicated time points and processed for western bloting according to the 
protocol shown in the Supplement. Membranes were probed with anti-Ob (MAB867, R&D Systems), 
anti-5-LOX (3289; Cell Signaling, Beverly, MA), anti-COX-2 (4842; Cell Signaling), anti–phospho-NF-
κBp65 Ser536 (3033; Cell Signaling), anti–phospho-STAT-3 Tyr705 (AF4607, R&D Systems) and anti–
β-actin (3700S; Cell Signalling). The Ag–Ab complexes were labelled with appropriate HRP-conjugated 
secondary Abs (Bio-Rad) and visualized by Immobilon Western HRP Substrate kit (Millipore, Bedford, 
MA). 
 
ELISA 
Supernatants of SZ95 sebocyte cultures maintained with/without leptin were collected at the indicated 
time points and were stored at −20°C until they were analyzed for the presence of IL-6, IL-8, TNF and 
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IL-1. Cytokine levels were measured using Quantikine ELISA reagents (R&D systems) according to the 
manufacturer’s instructions. 
 
Quantitative real-time PCR (qRT-PCR) 
To obtain total RNA, cells were centrifuged and pelleted at the indicated time points. RNA isolation, 
cDNA synthesis, qRT-PCR, used assays and quantification methods are detailed in Supplementary 
information online. 
 
Statistical analyses 
All data are presented as mean ± SD. In qRT-PCR experiments, the mean and SD were calculated for 
both the normalized and the normalizer values. To incorporate the random errors of the measurements, we 
used the propagation of errors to determine the SD of the normalized values. We made at least four 
biologic replicates for all experiments. In qRT-PCR experiments, we performed an unpaired, two-tailed, t 
test. Differences with p0.05 values were considered statistically significant.  
 
Results 
Ob-Rb is expressed in human sebaceous glands  
To address the possible role of leptin signalling in sebaceous gland biology, we first performed 
immunohistochemical analysis using a specific antibody for the Ob-Rb receptor subtype, which is 
responsible for active signal transduction in human skin samples of healthy individuals and acne patients. 
We found that Ob-Rb was expressed in the sebaceous glands of both the healthy, as well as the acne-
involved skin (Fig. 1a, b). 
Next, we turned our attention to human SZ95 sebocytes and used qRT-PCR, western blotting and 
immunohistochemical analyses to detect the expression of Ob-Rb at mRNA and protein levels. We found 
that Ob-Rb mRNA levels in SZ95 sebocytes were comparable with the levels detected in a human 
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immortalized keratinocyte cell line (HaCaT), in primary human keratinocytes (NHEK), as well as in 
human blood derived monocytes/macrophages (Fig. 1c). 
In line with the mRNA analysis, the expression of the Ob-Rb protein was detected by western blotting 
using an antibody that detected also the Ob-Ra variant (Fig. 1d). These results were later confirmed by 
immunostaining using an antibody specific for the Ob-Rb isoform (Fig. 1e).  
These findings confirmed SZ95 sebocytes as a valuable model for further investigations on addressing 
the role of leptin in sebocyte biology. 
 
Leptin alters lipogenesis in SZ95 sebocytes  
The primary function of sebocytes is their potential to synthetize lipids, therefore we investigated the 
early and late effects of leptin on the lipid profile of leptin-treated SZ95 sebocytes, assessing the synthesis 
of major sebaceous lipids such as squalene (SQ), cholesterol (CH), triglycerides (TG), free fatty acids 
(FFA), as well as alpha-tocopherol (vitamin E, VE). Briefly, cell samples were collected at 12 and 36 h 
after leptin treatment and compared to controls using various techniques such as high performance thin 
layer chromatography (HPTLC), gas-chromatography-mass spectrometry (GC-MS) and high performance 
liquid chromatography coupled with flight mass spectrometer mass detector (HPLC-ToF/MS).  
First, HPTLC with densitometric analysis showed that TG levels were significantly elevated in 
response to leptin at 36 h (+ 37%); in contrast to SQ, FFA and CH levels that did not change significantly 
(Fig. 2a). For a higher sensitivity and specificity, SQ and CH levels were simultaneously quantified by 
GC-MS. The extended analysis showed that while SQ levels were not modified over time in control 
sebocytes, its concentration tended to increase in the leptin-treated ones. In contrast, concentration of CH 
increased in a time-dependent manner in both the control and leptin-treated cells, and leptin treatment did 
not result in any significant change compared to the controls (Supplement 3). 
Next, in order to further investigate representative components of the human sebum such as different 
FFAs and TG lipid classes, samples were analyzed by HPLC-ToF/MS and GC-MS
21
. The evaluation of 
the summarized levels and calculated ratios of monounsaturated fatty acids/saturated fatty acids 
This article is protected by copyright. All rights reserved. 
(MUFA/SFA) and polyunsaturated fatty acids/saturated fatty acids (PUFA/SFA) showed significant 
differences in the PUFA/SFA ratios (control vs. leptin at 36 h, p<0.05) and was close to significance 
regarding the MUFA/SFA ratios (control vs. leptin at 12 h, p=0.07) (Fig. 2b). To assess which FFA ratios 
changed, an array of 16:1/16:0, 16:2/16:0, 18:1/18:0, 18:2/18:0, 18:3/18:0, 20:1/20:0, 20:2/20:0 and 
20:3/20:0 FFA was calculated resulting in significances (p<0.05) and tendencies (p<0.07) (Fig. 2c). The 
increase in the ratios of selected MUFA/SFA and PUFA/SFA, was confirmed via further analysis of TGs 
where the calculated ratios of 48:2/48:0 (control 1.69 ± 0.19 to 2.06 ± 0.20) and 48:3/48:0 (0.51 ± 0.07 
and 0.66 ± 0.01) changed significantly after 36 h (data not shown).  
The change of the cell redox status consequent to activation of lipid synthesis has barely been 
investigated in sebocytes. Thus, VE, which accounts for the major lipid scavenger of free radicals in the 
cell membrane, was also analyzed. The concentration of VE was significantly lower in leptin-treated 
sebocytes at 36 h (Fig. 2d).  
These data indicate that desaturation of FFA is an early effect of leptin treatment, whereas appreciable 
induction of TG synthesis occurs at later time points. Moreover a significant decrease in the VE levels 
indicated that leptin and its lipogenic effects could be associated with consumption of lipophilic 
antioxidants.  
 
Leptin treatment leads to lipid body enlargement in SZ95 sebocytes 
Sebocytes store and metabolize intracellular lipids in hydrophobic organelles called lipid bodies. In order 
to detect changes in the lipid body formation we used fluorescent microscopy to visualize the BODIPY 
stained lipid droplets (Fig. 3a-b). As sebocytes accumulate lipid droplets in high numbers with different 
sizes, we focused on the lipid droplets exceeding 3 m of size. We found that in the leptin-treated 
samples the number of cells with such lipid droplets was increased when compared with the untreated 
controls (Fig. 3c). As BODIPY staining is able to selectively stain lipid droplets it also allows FACS 
measurements for quantitative analyses
22
. In support to the previous findings, we confirmed that leptin–
treated SZ95 sebocytes exhibited an increased fluorescence intensity compared to control cells (Fig. 3d).  
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Altogether, these results indicate that leptin-treated SZ95 sebocytes display an altered lipid droplet 
formation. 
 
COX-2 and 5-LOX expression and inflammatory cytokine expression of SZ95 cells is increased by leptin  
To investigate the potential role of leptin in inflammation, first we measured the protein levels of COX-2 
and 5-LOX, the key enzymes in the production of inflammatory mediators in SZ95 sebocytes. Using 
western blot analysis we could show that the expression levels of COX-2 (Fig. 4a) and 5-LOX (Fig. 4b) 
were increased upon leptin treatment when compared to untreated cells. 
Next, we determined the effect of leptin on the expression of IL-6 and IL-8, shown to be important in 
the inflammatory signalling of human sebocytes
10,15
. In the presence of leptin the mRNA levels of both 
IL-6 and IL8 showed a marked up-regulation compared to untreated cells (Fig. 4d). Similar to this, the 
secreted IL-6 and IL-8 protein levels were also up-regulated, as detected by ELISA measurements (Fig. 
4e). On the other hand, we could not detect secretion of TNFα and IL1β by ELISA in any of the tested 
conditions, a finding that is consistent with previous reports suggesting that SZ95 sebocytes do not 
secrete these cytokines under normal conditions
16,23
. 
To exclude that the measured differences were related to a reduced cell viability we also performed an 
apoptosis assay at 12, 24 and 48 h time points and found no differences between the leptin-treated and the 
untreated control cells (Supplement 4).  
These data altogether show that SZ95 sebocytes respond to leptin stimulus with an enhanced 
expression of inflammatory enzymes and an increased production and secretion of pro-inflammatory 
cytokines.  
 
Leptin activates STAT-3 and NF-B pathways in SZ95 sebocytes 
The prime consequence of leptin binding to its receptor is the activation of the STAT-3 pathway leading 
to STAT-3 phosphorylation
24
, while on the other hand, NF-B also serves as a downstream signalling 
This article is protected by copyright. All rights reserved. 
mediator of leptin
25
. To explore the mechanisms by which leptin could increase the inflammatory 
response of SZ95 sebocytes we examined its effect on STAT-3 and NF-B activation. We measured and 
compared the intensity and length of the phosphorylation of STAT-3 and the NF-B p65 subunit in the 
control and leptin-treated SZ95 sebocytes during a 1-hour time period. Upon leptin treatment, both 
STAT-3 and p65 phosphorylation increased (Fig. 4c), showing that this treatment resulted in an increased 
STAT-3 and NF-B activity.  
These data suggest that leptin contributes to inflammation through the induction of STAT-3 and NF-
B signalling in SZ95 sebocytes. 
 
Discussion  
Sebaceous glands play a pivotal role in the development of the intact skin barrier through the production 
of sebum. Moreover, besides their active lipid metabolism
26-28
, sebocytes also play an important role in 
the setting of an inflammatory environment by being competent for the synthesis and secretion of pro-
inflammatory cytokines, such as IL-6 and IL-8. As a result, they are involved in the initiation of the 
pathogenesis of sebaceous gland associated diseases such as acne
18,29-31
.  
Leptin is an adipokine, secreted predominantly by adipocytes in response to increased lipid uptake
32
. 
Its serum concentration correlating with the body mass index, and the amount of the adipose tissue is 
responsible for its systemic effects through the leptin receptor in the hypothalamus. However, the role of 
leptin is not limited to the regulation of energy expenditure. Besides its metabolic effect, leptin modulates 
immune responses in many different cell types; adipocytes, macrophages
33
, dendritic cells
34
, T cells
35
, B 
cells
36
, natural killer cells
37
, chondrocytes
38
, fibroblasts
39
 and keratinocytes
40
 all seem to respond to leptin. 
Regarding its role in skin physiology, leptin was found to be an important player in skin regeneration and 
ageing, as well as in hair growth
39,41,42
. Considering the complex role of leptin in integrating lipid 
metabolism and inflammatory responses at a cellular level, it is intriguing to speculate that leptin 
signalling could be implicated into sebocyte biology, too. Supporting this hypothesis, leptin deficient 
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(ob/ob) mice were found to exhibit an increased sebaceous gland size
43
 with an abnormal production of 
type II wax diesters, which are important for water repulsion in mice
44
. However, using HE-stained 
sections for sebaceous gland size measurements and considering the fact that mouse sebum greatly differs 
from the human one (e.g. contains relatively small amounts of triglycerides
45
) conclusions are not easy to 
be made regarding human sebocyte biology. Moreover, the unavailability of animal models that exert 
sebaceous gland-associated human diseases, like acne, further suggests that besides the function also the 
pathology of sebaceous glands have changed with evolution. These findings altogether point towards a 
possible role for leptin in sebocyte biology, but call for further, cell-type specific studies on how leptin 
affects lipogenesis and inflammation in the human sebaceous cells.  
In our work evidence is provided that leptin receptor is expressed in the human sebaceous glands, 
besides the human epidermis
39
, human follicular papilla cells
46
 and the sebocyte-like cells of the rat 
preputial gland
47
, where it was previously detected. Interestingly, the expression of the Ob-Rb receptor 
was detected both in control and in acne samples, suggesting that these cells can readily respond to leptin 
under different conditions. In order to investigate how leptin could alter lipogenesis and inflammation in 
human sebocytes, we confirmed initially the presence of Ob-Rb in SZ95 sebocytes, followed by a 
comprehensive analysis of the outcomes of leptin stimulus, by measuring the changes in the lipid body 
formation, lipid profile and the pro-inflammatory responses with the possible signalling pathways behind 
it (Fig. 5).  
Lipid body formation is a phenomenon widely observed in lipid-metabolizing cells, however, their 
presence and dynamics have only been studied to a limited extent in these cell types
20
. Using BODIPY 
fluorescent staining, we found that leptin treatment was associated with an enlargement of the lipid 
droplets and increased fluorescence intensity within SZ95 sebocytes. Interestingly, the same phenomenon 
could also be observed in macrophages upon leptin treatment
48
, pointing out that leptin could affect 
intracellular lipid storage and metabolism, and depending on the cell type and model system used, 
lipolysis is not an obligate outcome alone. Noteworthy, the mechanisms controlling the formation of lipid 
bodies and the fate of intracellular lipids are likely to be influenced by the specific functions that the 
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different tissues carry out, e.g. the adipose tissue accumulates lipids to store excessive energy, whereas 
lipids being synthetized in the sebaceous glands are excreted to form the skin surface lipid film
49
. 
Moreover, a possible link between lipid body enlargement and sebum production was already addressed 
in a recent publication that aimed to characterize sebocytes of Cidea-deficient mice that exerted markedly 
reduced levels of skin surface lipids. While Cidea-deficient sebocytes with an impaired lipid production 
and secretion accumulated a large number of smaller-sized lipid droplets, the overexpression of Cidea in 
human SZ95 sebocytes resulted in an increased lipid storage and in an accumulation of large lipid 
droplets that were both correlated positively with human sebum secretion.
50
 These results put forward that 
in the leptin-treated sebocytes the enlargement of lipid droplets could be considered as a marker for 
increased lipid production and secretion, however more data on the formation, enlargement, function and 
fate of these lipid bodies are needed to understand their exact role in (leptin-treated) sebocytes. 
In order to detect the changes in the levels of lipids that are present in the human sebum, we exploited 
additional lipidomic analyses
21
 and provided evidence that similarly to other cell types capable of 
responding to leptin stimulus, leptin altered lipogenesis in SZ95 sebocytes, too. In this process 
desaturation of FFA might be a key event as revealed by the relative accumulation of different MUFAs 
and PUFAs. Furthermore, the increased ratios of the unsaturated/saturated FFA could explain the 
increased levels of TG at the later time points and also the enlargement of lipid bodies as unsaturated FFA 
were shown to induce TG at greater extents than the saturated ones and promoted TG-enriched lipid body 
formation in different cell types
51
.  
Giving biological relevance to these findings, the importance of the unsaturated/saturated lipid ratio in 
the sebum was addressed in a former publication showing that a decrease in unsaturated FFA vs. saturated 
FFA levels in sebum, especially marked by the FFA 16:1/16:0 ratio, was predictive of the clinical 
improvement in acne, suggesting that the desaturation of sebaceous fatty acids may be involved in acne 
development
52
. Interestingly, the authors also found that acne subjects on low glycemic load diet (LGL) 
showed a greater improvement, which correlated with the change in body mass and with the decrease in 
the levels of unsaturated FFA compared to the increase seen in the control group of patients on non 
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LGL
52
. Concluding their findings, they hypothesized that LGL diet may affect sebum composition via 
undefined metabolic effects in which, according to our understanding, leptin may be a key candidate. In 
our system, supporting this notion, we provide evidence that leptin might be implicated into the 
pathophysiology of acne by inducing an “acne-like” change in the sebaceous lipid profile via increasing 
the amounts of unsaturated FFA, especially the FFA 16:1/16:0 ratio, which largely resembles the changes 
in the composition of sebum found in acne patients. Moreover, the decrease in the levels of the major 
sebum antioxidant VE upon leptin treatment, which is also a hallmark in acne patients
39
, further supports 
a possible role for leptin in acne. 
Multiple lines of evidence indicate that the role of sebocytes is not limited to lipogenesis, but is also 
the modulation of inflammation. Previous reports have shown that, just as it was detected in the 
sebaceous glands of acne lesions, SZ95 sebocytes also express inflammatory enzymes (COX-2 and 5-
LOX), cytokines (IL-6) and chemokines (IL-8) at a basal level
15
. Moreover, their expression could be 
further induced upon treatment with various inflammatory stimuli including arachidonic acid, linoleic 
acid
53
, and P. acnes
16
. We showed that the expression of all these molecules were significantly increased 
upon leptin treatment supporting that leptin might also be a potential player in inducing inflammatory 
signalling in human sebocytes.  
Tyrosine phosphorylation close to the carboxy-terminus (Y705) and serine phosphorylation at a site 
within the transactivation domain (S727) of STAT-3 leads to its dimerization, nuclear translocation and 
DNA binding, resulting in the regulation of its target genes such as c-Myc, JunB, and Mcl-1
54
. NF-κB 
molecules are associated with IκB proteins in the cytoplasm that prevents their nuclear localization. Upon 
activation, the NF-κB is released and also translocates to the nucleus with a subsequent DNA binding 
leading to the expression of genes with specific response elements, in which the phosphorylated p65 
subunit of the NF-κB provides the gene regulatory function. By measuring the phosphorylation of STAT-
3 and p65 after leptin stimulus we found evidence that in leptin-treated SZ95 sebocytes STAT-3 and NF-
κB pathways are likely candidates for the mechanisms behind the enhanced inflammatory cytokine 
production. This is also the first report showing that STAT-3 signalling could be induced in SZ95 
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sebocytes, adding important details on the complexity of inflammatory pathways that are active in human 
sebocytes (Fig. 5).  
Based on our findings one might speculate on the association of serum leptin levels with acne. The 
available data from clinical studies also support that leptin may contribute to sebaceous gland pathology 
as the serum leptin levels in obese subjects with acne were significantly higher than in obese subjects 
without acne
55
. However, no significant differences were observed in non-obese adolescents with or 
without acne
56
, calling for further studies to define the exact (metabolic) conditions where leptin could 
affect sebum production and inflammation. Furthermore, since leptin might also be of skin origin, as 
keratinocytes, fibroblasts and subcutaneous adipocytes were also found to synthetize and secrete leptin 
upon various stimuli
39
, leptin could also act as a cutaneous transmitter, of which sebocytes are primary 
targets. Our present work therefore opens new avenues for further investigations that may integrate leptin 
into the currently modified concepts
57
 of (patho)physiological signalling in sebaceous gland-associated 
diseases, such as acne.  
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Figures legends 
Figure 1. Leptin receptor Ob-Rb is present in the sebaceous glands of normal and acne-involved 
skin and is expressed in SZ95 sebocytes. Leptin receptor Ob-Rb protein immunostaning of human 
sebaceous glands in control (a) and acne (b) skin samples as described in Materials and Methods. 
Original magnification ×200. (c) Leptin receptor Ob-Rb mRNA expression in HaCaT keratinocytes, 
NHEK keratinocytes, human blood derived monocytes/macrophages, and SZ95 sebocytes determined by 
RT-Q-PCR. All PCR data are expressed as a ratio of the leptin receptor Ob-Rb transcripts relative to -
actin expression. The expression levels are representative of three independent measurements. Error bars 
indicate the SD of the relative expression. (d) Western blot analysis of leptin receptors Ob-Rb and Ob-Ra 
by using an antibody that targets both Ob-R isoforms. The images are representative of three different 
blots. (e) Digitized images of immunofluorescently labeled SZ95 sebocytes stained with selective Ob-Rb 
antibody. Scale bar: 10μm. 
Figure 2. Leptin affects lipogenesis in SZ95 sebocytes by increasing triglyceride levels, increasing 
the ratios of unsaturated/saturated fatty acid levels and by decreasing the level of vitamin E (a) 
Densitometric analysis of bands (squalene (SQ), triglycerides (TG), free fatty acids (FFA), cholesterol 
(CH) obtained by HPTLC (average  SD of normalized intensity) of lipid extracts from SZ95 sebocytes 
treated with leptin for the indicated time points, showing that leptin induced the levels of triglycerides at a 
significant extent at 36 h (*p0.05). (b) FFA were quantified following separation with HPLC and 
detection with a ToF/MS detector at the respective treatment time with leptin (12 and 36 h). Ratios of 
MUFA/SFA and PUFA/SFA were calculated showing a significant change in the case of PUFA/SFA 
(CTR vs. LEPT at 36h, p<0.05) and being close to significance in the case of MUFA/SFA (c) Array of 
calculated ratios of representative human sebum components ranging from 16:1/16:0, 16:2/16:0, 
18:1/18:0, 18:2/18:0, 18:3/18:0, 20:1/20:0, 20:2/20:0 and 20:3/20:0 resulting in significances (p<0.05) 
and tendencies (p<0.07) showing that leptin affected the distribution of FFA. [*p0.05 **p0.005 (leptin 
vs. control)]. (d) Concentration of vitamin E (alpha-tocopherol) in SZ95 sebocytes was significantly 
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lower in leptin treated sebocyte cells at 36 h (*p0.05) as determined by GC/MS. The data were reported 
mean  SD of the concentrations determined in 4 independent experiments.  
Figure 3. Leptin treatment increased lipid body size. Representative images of BODIPY and a blue 
nuclear counterstained SZ95 sebocytes that were (a) untreated or (b) treated with leptin and observed by 
fluorescence microscopy as described in Materials and Methods (original magnification, X100). Red 
arrows point to lipid bodies with an increased size that are characteristic for leptin-treated cells. 
Enumeration of lipid bodies with a size exceeding 3 m (c) in untreated and leptin-treated SZ95 
sebocytes at 12 and 24 h after stained with BODIPY and a blue nuclear counterstain. 4X100 cells from 
groups were analysed in each sample as detailed in Supplement 2. Bars represent the mean ± SEM from 
four independent experiments. Intensity of BODIPY staining was determined by flow cytometry on SZ95 
sebocytes (d) treated with vehicle (Control) (filled gray) or leptin (black line). Numbers are the mean 
fluorescence intensity values. One representative experiment of four performed is shown. 
Figure 4. Leptin treatment increases COX-2 and 5-LOX expression, activates STAT-3 and NF-κB 
signalling and increases the secretion of inflammatory cytokines. Western blot analysis of (a) COX-2 
(b) 5-LOX and phosphorylation of (c) STAT-3 Tyr705 and NF-κBp65 Ser536 as well as -actin 
expression in untreated (control) and leptin-treated SZ95 sebocytes for the indicated periods of time. The 
images are representative of at least three different blots. (d) The mRNA levels for IL-6 and IL8 in SZ95 
sebocytes stimulated with leptin for 2 h. Expression levels were determined by real-time quantitative RT-
Q-PCR. Data are expressed as a ratio of the transcripts relative to -actin expression. Error bars indicate 
the SD of the relative expression. *p < 0.03, compared with the respective control value. (e) Relative 
protein levels of IL-6 and IL-8 from supernatants of SZ95 sebocytes treated with leptin for the indicated 
time points were determined by ELISA as described in Materials and Methods. Data were normalized 
with protein levels similarly determined from untreated SZ95 sebocytes of the same experiment 
(treated/untreated). Data show the means and SEM of five independent experiments. Significance versus 
untreated cells **p < 0.05.  
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Figure 5. Leptin integrates into sebocyte biology - mechanisms involved in the leptin-treated SZ95 
sebocytes. Activation with leptin is resulted in the up-regulation of inflammatory enzymes COX-2 and 5-
LOX and in the increased expression and secretion of inflammatory cytokines IL-6 and IL-8 that is likely 
to be underpinned by the activation of the STAT-3 and NF-B pathways. Treatment with leptin also 
resulted in an altered lipogenesis by increasing the ratio of monounsaturated fatty acids/saturated fatty 
acids (MUFA/SFA) and polyunsaturated FFA/saturated FFA (PUFA/SFA) and reducing the level of 
vitamin E. The enlargement of lipid droplets upon leptin treatment correlated with the increased levels of 
unsaturated FFA and TG. 
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